Therapeutic impact of epidermal growth factor receptor tyrosine kinase inhibitor with various treatment combinations for advanced lung adenocarcinoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Therapeutic impact of epidermal growth factor receptor tyrosine kinase inhibitor with various treatment combinations for advanced lung adenocarcinoma ; volume:21 ; number:1 ; day:13 ; month:10 ; year:2023 ; pages:1-10 ; date:12.2023
World journal of surgical oncology ; 21, Heft 1 (13.10.2023), 1-10, 12.2023
- Creator
-
Chen, Ying-Yi
Lin, Kuan-Hsun
Kuo, Yen-Shou
Tsai, Yuan-Ming
Huang, Hsu-Kai
Huang, Tsai-Wang
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12957-023-03203-6
- URN
-
urn:nbn:de:101:1-2024020907454201841850
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Chen, Ying-Yi
- Lin, Kuan-Hsun
- Kuo, Yen-Shou
- Tsai, Yuan-Ming
- Huang, Hsu-Kai
- Huang, Tsai-Wang
- SpringerLink (Online service)
Other Objects (12)
Comparison of epidermal growth factor receptor tyrosine kinase inhibitors for patients with lung adenocarcinoma harboring different epidermal growth factor receptor mutation types
Mental disorder or conscious disturbance in epidermal growth factor receptor-tyrosine kinase inhibitor treatment of advanced lung adenocarcinoma
Various Combinations of Flame Retardants for Poly (vinyl chloride)
Canine pulmonary adenocarcinoma tyrosine kinase receptor expression and phosphorylation
Progress toward resistance mechanism to epidermal growth factor receptor tyrosine kinase inhibitor
Management of medically inoperable and tyrosine kinase inhibitor-naïve early-stage lung adenocarcinoma with epidermal growth factor receptor mutations: a retrospective multi-institutional analysis
Prognostic value of localization of epidermal growth factor receptor in lung adenocarcinoma
Neue Inhibitoren der Epidermal Growth Factor related Tyrosine Phosphokinase (EGFrTK), CARN 79079-06-4
Evaluation of Patients with Lung Cancer Treated with Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor
Case report: small cell transformation and metastasis to the breast in a patient with lung adenocarcinoma following maintenance treatment with epidermal growth factor receptor tyrosine kinase inhibitors
Prognostic utility of epidermal growth factor receptor (EGFR) expression in prostatic acinar adenocarcinoma
Combinations-Linien.
Comparison of epidermal growth factor receptor tyrosine kinase inhibitors for patients with lung adenocarcinoma harboring different epidermal growth factor receptor mutation types
Mental disorder or conscious disturbance in epidermal growth factor receptor-tyrosine kinase inhibitor treatment of advanced lung adenocarcinoma
Various Combinations of Flame Retardants for Poly (vinyl chloride)
Canine pulmonary adenocarcinoma tyrosine kinase receptor expression and phosphorylation
Progress toward resistance mechanism to epidermal growth factor receptor tyrosine kinase inhibitor
Management of medically inoperable and tyrosine kinase inhibitor-naïve early-stage lung adenocarcinoma with epidermal growth factor receptor mutations: a retrospective multi-institutional analysis
Prognostic value of localization of epidermal growth factor receptor in lung adenocarcinoma
Neue Inhibitoren der Epidermal Growth Factor related Tyrosine Phosphokinase (EGFrTK), CARN 79079-06-4
Evaluation of Patients with Lung Cancer Treated with Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor
Case report: small cell transformation and metastasis to the breast in a patient with lung adenocarcinoma following maintenance treatment with epidermal growth factor receptor tyrosine kinase inhibitors
Prognostic utility of epidermal growth factor receptor (EGFR) expression in prostatic acinar adenocarcinoma
Combinations-Linien.
Comparison of epidermal growth factor receptor tyrosine kinase inhibitors for patients with lung adenocarcinoma harboring different epidermal growth factor receptor mutation types
Mental disorder or conscious disturbance in epidermal growth factor receptor-tyrosine kinase inhibitor treatment of advanced lung adenocarcinoma
Various Combinations of Flame Retardants for Poly (vinyl chloride)
Canine pulmonary adenocarcinoma tyrosine kinase receptor expression and phosphorylation
Progress toward resistance mechanism to epidermal growth factor receptor tyrosine kinase inhibitor
Management of medically inoperable and tyrosine kinase inhibitor-naïve early-stage lung adenocarcinoma with epidermal growth factor receptor mutations: a retrospective multi-institutional analysis
Prognostic value of localization of epidermal growth factor receptor in lung adenocarcinoma
Neue Inhibitoren der Epidermal Growth Factor related Tyrosine Phosphokinase (EGFrTK), CARN 79079-06-4
Evaluation of Patients with Lung Cancer Treated with Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor
Case report: small cell transformation and metastasis to the breast in a patient with lung adenocarcinoma following maintenance treatment with epidermal growth factor receptor tyrosine kinase inhibitors
Prognostic utility of epidermal growth factor receptor (EGFR) expression in prostatic acinar adenocarcinoma